PIB Government of India Press Briefing - 12th January 2021
←
→
Page content transcription
If your browser does not render page correctly, please read the page content below
Government of India
PIB
Press Briefing
12th January 2021
Covid-19 situation is worrisome across the world
USA UK Brazil 87k
400k 68K
Russia 29k South Africa 21k
India
Country Trajectory as on 11th January 2021;
Source: coronavirus.jhu.edu;
1,000,000
0
200,000
400,000
600,000
800,000
30-Jun
7-Jul
215,125
14-Jul
21-Jul
28-Jul
4-Aug
11-Aug
18-Aug
673,166
25-Aug
1-Sep
8-Sep
15-Sep
990,061
22-Sep
29-Sep
6-Oct
13-Oct
20-Oct
27-Oct
748,538
3-Nov
10-Nov
17-Nov
24-Nov
1-Dec
8-Dec
15-Dec
Active cases continue to decline, now less 2.2 lakhs
22-Dec
29-Dec
5-Jan
12-Jan
216,558
India: Covid-19 Snapshot
Total cases Active cases Deaths Tests
1.04 2.16 1.51 18.2
crore lakhs lakhs crores
Case Per Million Contribution Death Per Million Tests Per Million
7,593 2.07% 109 132,357
Case Positivity Case Fatality Rate
5.7% 2.0% 1.44% 1.20%
(Overall) (Last 1 week) (Overall) (Last 1 week)
Only 2 States/UTs with more than 50,000 cases contribute 54%
State Active Cases
Kerala 63,547
Maharashtra 53,463Present Status of Active Cases
56.04%
43.96%
Patients in Health Care Facilities Patients in Home IsolationProactive & Preemptive Action by India • To promote indigenous R&D in vaccines, pharmaceuticals & diagnostics, a “Task Force” headed by PSA set up in May 2020. • To address vaccine procurement, logistics, prioritization of population groups etc. “NEGVAC” headed by Member (Health) NITI & Secretary, Health & Family Welfare set up in August 2020.
Emergency Use Authorization (EUA) to two vaccines in India
Two COVID-19 vaccines-
Both the vaccines have
Covishield & Covaxin-
established safety &
have received Emergency
immunogenicity
Use Authorization (EUA)Possible timelines of other vaccines under trials in India
Vaccine Dec’20 Jan’21 Feb’21 Mar’21
II III
Zydus Cadila
trials complete trials beginning
II & III
Sputnik V
trials ongoing
I I II
Biological E
trials started trials ongoing may begin
I II
Gennova
trials approved may beginVaccine Scenario: The World
Price per dose Storage
S. No. Producer Name Type Price per dose (INR)
(USD) Temp
1 Pfizer-BioNTech Tozinameran mRNA 19.50 1431 -70º C
2 Moderna mRNA-1273 mRNA 32 - 37 2348 – 2715 2-8º C
3 Sinopharm BBIBP-CorV Inactivated < 77 < 5650 2-8º C
4 Sinovac Biotech CoronaVac Inactivated 14 1027 2-8º C
5 Novavax NVX-CoV2373 Protein subunit 16 1114 2-8º C
6 Gamaleya Centre Sputnik V Viral vector < 10 < 734 2-8º C
Johnson &
7 JNJ-78436735 Viral vector 10 734 2-8º C
JohnsonVaccines in India • 110 lakh doses of COVISHIELD vaccine are being procured from SII at the cost of Rs. 200/dose (excluding taxes). • 55 lakh doses of COVAXIN vaccine are being procured from BBIL. • Cost of 38.5 lakh doses of COVAXIN is Rs. 295/dose (excluding taxes). • BBIL is providing 16.5 lakh doses of COVAXIN free of cost to the Central government. • Hence, the cost of COVAXIN is Rs. 206/dose.
Preparations for roll-out of COVID-19 vaccine Close collaboration with All preparations on track for States/UTs for vaccine roll-out COVID-19 vaccine roll-out from preparedness 16th January 2021 26 virtual meetings/trainings held with States/UTs, 2360 Master Trainers, 61,000 Programme Managers, 2 lakh Vaccinators, 3.7 lakh other Vaccination Team Members trained so far.
Key Principles for COVID-19 Vaccination Ensure people’s participation (Jan Bhagidari) Utilize experience of elections (booth strategy) and Universal Immunization Program No compromise of existing healthcare services, especially national programs and primary health care No compromise on scientific and regulatory norms, other SOPs Orderly, smooth implementation driven by technology
Sequential roll-out of COVID-19 vaccination
Health Care Workers (approx. 1 crore)
Public Health Facilities Front Line Workers (approx. 2 crore)
Pvt. Health Facilities Prioritized Age-groups
State and Central Police personnel
(approx. 27 crore)
Armed Forces personnel
> 50 years
Home Guards, Civil Defense & Disaster
Management Volunteers < 50 years with Co-
Municipal Workers morbidities
Prison staff
Revenue workers involved in
containment and surveillance
Cost of vaccination of Health Care Workers & Front Line Workers will be borne by Central Govt.National Level and State Level Vaccine Stores • 4 GMSDs at Karnal, Kolkata, Chennai, and Mumbai. • All states have at least one state level regional vaccine store. • Uttar Pradesh has 9, Madhya Pradesh has 4, Gujarat has 4, Kerala has 3, J&K has 2, Karnataka has 2 and Rajasthan has 2 stores.
Arrival of Doses at 4 pm on 12/01/2021 • 54,72,000 doses received. • 100% doses to be received by 14th Jan 2021 in all states/UTs.
IEC material for session sites
States/UTs also to prepare in Regional LanguagesExpectations from States/UTs All logistics to be ready for COVID-19 vaccination roll-out from 16th January 2021. Continuous oversight & personal involvement on the entire process of roll-out. Special focus on communication activities & utilization of all types of channels to create an encouraging environment, vaccines are safe & immunogenic. There is a gap of 28 days between 2 doses. 14 days after the second dose, the effectiveness begins. Communication must highlight this aspect & COVID Appropriate Behaviour.
Thank You
You can also read
